MD65Y - Noninvasive method for treating mammary fibroadenoma - Google Patents

Noninvasive method for treating mammary fibroadenoma

Info

Publication number
MD65Y
MD65Y MDS20090064A MDS20090064A MD65Y MD 65 Y MD65 Y MD 65Y MD S20090064 A MDS20090064 A MD S20090064A MD S20090064 A MDS20090064 A MD S20090064A MD 65 Y MD65 Y MD 65Y
Authority
MD
Moldova
Prior art keywords
tumor
mammary gland
fibroadenoma
treatment
noninvasive method
Prior art date
Application number
MDS20090064A
Other languages
Romanian (ro)
Inventor
Vitalie Machidon
Vasile Jovmir
Original Assignee
Vitalie Machidon
Vasile Jovmir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitalie Machidon, Vasile Jovmir filed Critical Vitalie Machidon
Priority to MDS20090064A priority Critical patent/MD65Z/en
Publication of MD65Y publication Critical patent/MD65Y/en
Publication of MD65Z publication Critical patent/MD65Z/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Inventia se refera la medicina, in special la oncologia glandei mamare si poate fi utilizata pentru tratamentul neinvaziv al fibroadenomului glandei mamare. Esenta metodei consta in aceea ca se actioneaza asupra tumorii cu unde electromagnetice cu o frecventa de 915 MHz, timp de 30 min. Rezultatul inventiei consta in disparitia tumorii intr-un timp scurt, evitarea complicatiilor posibile si reducerea de doua ori a numarului de zile de spitalizare. The invention relates to medicine, in particular to mammary gland oncology and may be used for non-invasive treatment of mammary gland fibroadenoma. The essence of the method is that it acts on the tumor with electromagnetic waves with a frequency of 915 MHz, for 30 minutes. The result of the invention consists in the disappearance of the tumor in a short time, avoiding the possible complications and reducing the number of days of hospitalization twice.

Description

[0001] Invenţia se referă la medicină, în special la oncologia glandei mamare şi poate fi utilizată pentru tratamentul neinvaziv al fibroadenomului glandei mamare.The invention relates to medicine, in particular to breast oncology and can be used for non-invasive treatment of fibroadenoma of the breast.

[0002] Este cunoscută metoda de tratament al fibroadenomului glandei mamare, care constă în administrarea hormonoterapiei cu preparate hormonale de tipul Tamoxifenului şi Danazolului, iar în cazul unui tratament neeficient se efectuează rezecţie sectorială sau enuclearea tumorii [1].[0002] The method of treatment of mammary gland fibroadenoma is known, which consists in administering hormone therapy with hormonal preparations such as Tamoxifen and Danazol, and in case of ineffective treatment, sectoral resection or enucleation of the tumor is performed [1].

[0003] Dezavantajele metodei cunoscute constau în aceea că în caz de tumoare benignă a glandei mamare, numită fibroadenom, se efectuează intervenţie chirurgicală în volum de rezecţie sectorială, enuclearea tumorii, care este urmată, de regulă, de un traumatism, fie şi neînsemnat, al glandei mamare, de o mutilare parţială, fie şi neînsemnată, precum şi de o cicatrice practic obligatorie. Accentuăm prezenţa obligatorie a efectului negativ psihologic - la gândul unei intervenţii chirurgicale, precum şi la eventualele posibilităţi de dezvoltare a unor complicaţii postoperatorii în cazul efectuării intervenţiei chirurgicale cu anestezie locală, aşa ca: alergie, supurare, insuficienţa suturilor, hemoragie etc. În aşa condiţii pacienta este supusă unui risc sporit de apariţie şi dezvoltare a mai multor complicaţii nedorite.[0003] The disadvantages of the known method are that in the case of a benign tumor of the mammary gland, called fibroadenoma, a surgical intervention is performed in the volume of sectoral resection, enucleation of the tumor, which is usually followed by a trauma, even if insignificant, of the mammary gland, by a partial mutilation, even if insignificant, as well as by a practically obligatory scar. We emphasize the obligatory presence of a negative psychological effect - at the thought of a surgical intervention, as well as the possible possibilities of developing postoperative complications in the case of performing the surgical intervention with local anesthesia, such as: allergy, suppuration, insufficiency of sutures, hemorrhage, etc. In such conditions, the patient is subject to an increased risk of the appearance and development of several undesirable complications.

[0004] Problema pe care o rezolvă invenţia constă în elaborarea unei metode neinvazive de tratament al fibroadenomului, care are efect curativ şi nu duce la agravarea stării generale, cauzată de efectul negativ psihologic, de dereglările estetice şi complicaţiile postoperatorii posibile, care nu este contraindicată pacientelor cu patologii concomitente, precum şi micşorarea numărului de zile de spitalizare.[0004] The problem solved by the invention consists in developing a non-invasive method of treating fibroadenoma, which has a curative effect and does not lead to worsening of the general condition, caused by the negative psychological effect, aesthetic disorders and possible postoperative complications, which is not contraindicated for patients with concomitant pathologies, as well as reducing the number of days of hospitalization.

[0005] Esenţa metodei constă în aceea că se acţionează asupra tumorii cu unde electromagnetice cu o frecvenţă de 915 MHz, timp de 30 min.[0005] The essence of the method consists in acting on the tumor with electromagnetic waves with a frequency of 915 MHz, for 30 min.

[0006] Rezultatul invenţiei constă în dispariţia tumorii într-un timp scurt, evitarea complicaţiilor posibile şi reducerea de două ori a numărului de zile de spitalizare.[0006] The result of the invention consists in the disappearance of the tumor in a short time, the avoidance of possible complications and the reduction of the number of days of hospitalization by two.

[0007] Tumoarea, în comparaţie cu ţesutul normal, manifestă un comportament metabolic diferit la aplicarea hipertermiei. În tumori consumul de oxigen scade la temperaturi de peste 40°C, intensificând procesul de glicoliză aerobă şi creşterea cantităţii de acid lactic. Din cauza acidităţii tisulare severe în aria tumorală, eritrocitele îşi pierd flexibilitatea, formând numeroşi trombi şi ocluzii ale microcirculaţiei. Datorită unei circulaţii sangvine reduse, mai ales în zona centrală a tumorii, valoarea acidităţii creşte, stimulând activitatea lizozomală. Enzimele lizozomale au o activitate maximă la pH 5,0…5,5, devenind maxim distructive. Totodată hipertermia provoacă schimbări distrofice, necrotice şi necrobiotice sub formă de vacuolizări, descompunerea poliribozomilor şi distrugerea lizozomilor (Overgaard J. Effect of hypertermia on malignant cells in vivo. Cancer, 1977, № 39, p. 2637-2646).[0007] Tumors, in comparison with normal tissue, exhibit a different metabolic behavior upon application of hyperthermia. In tumors, oxygen consumption decreases at temperatures above 40°C, intensifying the process of aerobic glycolysis and increasing the amount of lactic acid. Due to severe tissue acidity in the tumor area, erythrocytes lose their flexibility, forming numerous thrombi and occlusions of the microcirculation. Due to reduced blood circulation, especially in the central area of the tumor, the acidity value increases, stimulating lysosomal activity. Lysosomal enzymes have a maximum activity at pH 5.0…5.5, becoming maximally destructive. At the same time, hyperthermia causes dystrophic, necrotic and necrobiotic changes in the form of vacuolization, decomposition of polyribosomes and destruction of lysosomes (Overgaard J. Effect of hyperthermia on malignant cells in vivo. Cancer, 1977, № 39, p. 2637-2646).

[0008] În cazul aplicării corecte hipertermia este, în general, bine tolerată de către paciente şi nu produce leziuni în ţesuturile normale.[0008] When applied correctly, hyperthermia is generally well tolerated by patients and does not cause damage to normal tissues.

[0009] Căldura obţinută de ţesuturile normale din vecinătatea tumorii în timpul tratamentului hipertermic este eliminată prin evaporare, prin creşterea fluxului sangvin periferic şi, mai puţin, prin ventilare (Mustea I. Tratamentul tumorilor canceroase prin hipertermie. Cancerologie, Bucureşti. Vol. II, 1988, p. 604).[0009] The heat obtained by normal tissues in the vicinity of the tumor during hyperthermic treatment is eliminated by evaporation, by increasing peripheral blood flow and, to a lesser extent, by ventilation (Mustea I. Treatment of cancerous tumors by hyperthermia. Cancerology, Bucharest. Vol. II, 1988, p. 604).

[0010] Pentru tratamentul neinvaziv al fibroadenomului glandei mamare este utilizată instalaţia PLOT, care reprezintă un generator de oscilaţii electromagnetice ce include un magnetron cu o frecvenţă de 915 MHz. Energia este transmisă sarcinii cu ajutorul unui sistem de cuplaj, reprezentând un ghid de unde, care are formă dreptunghiulară şi canalizează unda electromagnetică emisă de o antenă. Pentru menţinerea temperaturii constante într-o anumită profunzime este necesară o răcire superficială care se obţine cu apa care circulă prin ghidaje. Temperatura de ieşire a agentului (temperatura în tumoare) este controlată printr-un sistem computerizat al instalaţiei. Unda electromagnetică, emisă de antenă, menţine o temperatură constantă la o profunzime de 5…7 cm pe o suprafaţă de 2…10 cm.[0010] For the non-invasive treatment of fibroadenoma of the mammary gland, the PLOT installation is used, which is a generator of electromagnetic oscillations that includes a magnetron with a frequency of 915 MHz. The energy is transmitted to the load using a coupling system, representing a waveguide, which has a rectangular shape and channels the electromagnetic wave emitted by an antenna. To maintain the constant temperature at a certain depth, a superficial cooling is required, which is obtained with water circulating through the guides. The output temperature of the agent (the temperature in the tumor) is controlled by a computer system of the installation. The electromagnetic wave, emitted by the antenna, maintains a constant temperature at a depth of 5…7 cm on a surface of 2…10 cm.

[0011] Avantajele invenţiei constau în aceea că tratamentului propus pot fi supuse paciente de diversă vârstă, paciente cu patologii asociate, care nu pot fi supuse tratamentului chirurgical cu utilizarea anesteziei locale sau generale, are un efect curativ sporit şi nu duce la agravarea stării generale, care este cauzată de efectul negativ psihologic al pacientei, de dereglările estetice şi complicaţiile postoperatorii posibile, precum şi în micşorarea numărului de zile de spitalizare.[0011] The advantages of the invention are that the proposed treatment can be applied to patients of various ages, patients with associated pathologies, who cannot undergo surgical treatment using local or general anesthesia, has an increased curative effect and does not lead to a worsening of the general condition, which is caused by the negative psychological effect of the patient, aesthetic disorders and possible postoperative complications, as well as in reducing the number of days of hospitalization.

[0012] Metoda se realizează în modul următor.The method is carried out in the following manner.

[0013] Pacienta se internează şi se examinează clinic şi paraclinic, şi anume citologic sau morfologic pentru stabilirea diagnosticului de fibroadenom al glandei mamare.[0013] The patient is admitted and examined clinically and paraclinically, namely cytologically or morphologically to establish the diagnosis of fibroadenoma of the mammary gland.

[0014] Asupra tumorii se aplică undele electromagnetice cu ajutorul unui emiţător cu o frecvenţă de 915 MHz, timp de 30 min. Tratamentul constă dintr-o singură şedinţă. Conform metodei elaborate au fost tratate 4 paciente cu efect pozitiv. Complicaţii în timpul efectuării acestui tratament nu au fost. Două paciente sunt observate mai mult de 10 ani cu efect clinic favorabil.[0014] Electromagnetic waves are applied to the tumor using a transmitter with a frequency of 915 MHz for 30 min. The treatment consists of a single session. According to the developed method, 4 patients were treated with a positive effect. There were no complications during this treatment. Two patients are observed for more than 10 years with a favorable clinical effect.

[0015] Exemplu[0015] Example

[0016] Pacienta M., a.n. 1965, s-a adresat la Institutul Oncologic cu acuze la prezenţa unei formaţiuni în glanda mamară stângă. Clinic în cadranul lateral inferior al glandei mamare stângi se apreciază o formaţiune de consistenţă dură, ovala, certă, mobilă cu diametru 1,0x1,5 cm. Examen ecografic - în cadranul lateral inferior al glandei mamare stângi se determină o formaţiune bine limitată, suprafaţă netedă, cu dimensiuni 1,0x1,5 cm, caracteristic pentru fibroadenom. Examen citologic - celule epiteliale glandulare. Tumoarea a fost supusă acţiunii hipertermiei cu unde electromagnetice cu o frecvenţă de 915 MHz, timp de 30 min.[0016] Patient M., born in 1965, addressed the Oncological Institute with accusations of the presence of a formation in the left mammary gland. Clinically in the lower lateral quadrant of the left mammary gland a formation of hard consistency, oval, definite, mobile with a diameter of 1.0x1.5 cm is appreciated. Ultrasound examination - in the lower lateral quadrant of the left mammary gland a well-limited formation is determined, smooth surface, with dimensions of 1.0x1.5 cm, characteristic of fibroadenoma. Cytological examination - glandular epithelial cells. The tumor was subjected to the action of hyperthermia with electromagnetic waves with a frequency of 915 MHz, for 30 min.

[0017] La controlul repetat peste 3, 5 şi 8 ani după tratament, date pentru tumoare a glandelor mamare nu au fost.[0017] At repeated control over 3, 5 and 8 years after treatment, data for mammary gland tumor were not.

[0018] 1. Mihail Pricop. Glanda mamară. ANKAROM, Iaşi, 1995, p. 118-121[0018] 1. Mihail Pricop. Mammary gland. ANKAROM, Iaşi, 1995, p. 118-121

Claims (1)

1. Metodă de tratament neinvaziv al fibroadenomului glandei mamare, care constă în aceea că se acţionează asupra tumorii cu unde electromagnetice cu o frecvenţă de 915 MHz, timp de 30 min1. Method of non-invasive treatment of fibroadenoma of the mammary gland, which consists in acting on the tumor with electromagnetic waves with a frequency of 915 MHz, for 30 min.
MDS20090064A 2009-04-23 2009-04-23 Noninvasive method for treating mammary fibroadenoma MD65Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20090064A MD65Z (en) 2009-04-23 2009-04-23 Noninvasive method for treating mammary fibroadenoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20090064A MD65Z (en) 2009-04-23 2009-04-23 Noninvasive method for treating mammary fibroadenoma

Publications (2)

Publication Number Publication Date
MD65Y true MD65Y (en) 2009-08-31
MD65Z MD65Z (en) 2010-03-31

Family

ID=41120163

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20090064A MD65Z (en) 2009-04-23 2009-04-23 Noninvasive method for treating mammary fibroadenoma

Country Status (1)

Country Link
MD (1) MD65Z (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2827G2 (en) * 2005-03-04 2006-04-30 Михаил СУРГУЧ method of prophylaxis of the dishormonal mammary hyperplasiae
MD3041G2 (en) * 2005-10-07 2006-12-31 Ион МЕРЕУЦЭ Method of mamma dishormonal dysplasia prophylaxis
MD3678G2 (en) * 2007-06-08 2009-03-31 Общественное Медико-Санитарное Учреждение Научно-Исследовательский Институт В Области Охраны Матери И Ребенка Method of diffuse mastopathy treatment
  • 2009

Also Published As

Publication number Publication date
MD65Z (en) 2010-03-31

Similar Documents

Publication Publication Date Title
HUE073220T2 (en) Kat6 inhibitor and combinations for breast cancer treatment
EP3952984C0 (en) Devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
IL280707B2 (en) Diagnostic and therapeutic methods for the treatment of breast cancer
NZ587057A (en) Method of treating prostate cancer with the gnrh antagonist degarelix
IL308766A (en) Compositions and methods for the treatment of prostate cancer
WO2009075879A8 (en) Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
MX2019004549A (en) Combinations comprising an ssao/vap-1 inhibitor and a sglt2 inhibitor, uses thereof.
PH12021551235A1 (en) Elacestrant in combination with abemaciclib in women with breast cancer
MX2020008680A (en) Combination therapy with apilimod and glutamatergic agents.
AU201814591S (en) Ultrasound therapeutic treatment transducer
IT202000000454A1 (en) COMPOSITIONS INCLUDING AMINO ACIDS FOR THE PREVENTION AND TREATMENT OF CANCER
SMT202500434T1 (en) Sotorasib for use in the treatment of cancer
IL279277A (en) In vivo controlled combination therapy for treatment of cancer
MX2019008233A (en) Targeted doxorubicin-gold nanoconjugates for tumor therapy.
GB202317288D0 (en) Pyrrolopyridone derivatives useful in the treatment of cancer
IL321393A (en) Ctps1 inhibitors for use in the treatment of ctps2 deficient cancer
IL308992A (en) Treatment of cancer in patients with soluble fr-alpha
MX2020008881A (en) Methods of treatment of cancer comprising chk1 inhibitors.
PL4294395T3 (en) Treatment of breast cancer using combination therapies comprising gdc-9545 and gdc-0077
MX2021002884A (en) Combination therapy for the treatment of prostate cancer.
IL302635B1 (en) Methods and apparatuses for determining transducer locations to generate tumor treating fields
IL292239A (en) Pegylated kynureninase enzymes and uses thereof for the treatment of cancer
MD65Z (en) Noninvasive method for treating mammary fibroadenoma
GB202107994D0 (en) Treatment of cancer
IL326327A (en) Prostate cancer treatment

Legal Events

Date Code Title Description
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
MM4Y Short-term patent definitely lapsed due to non-payment of fees